01 About The Lancet
The Lancet, published by Elsevier BV, is one of the most widely cited and broadly read medical and health sciences journals in the world. With a catalogue of 475,532 works and a cumulative cited-by count of 10,311,533, it occupies a singular position in the global research landscape. Its h-index of 1,201 reflects decades of publishing work that has shaped clinical practice, public health policy, and health-related social science. The journal's two-year mean citedness of 17.86 reflects the reach of the research it publishes.
While The Lancet is anchored in medicine and health professions, its top concept scores reveal a genuinely multidisciplinary scope. Social sciences, economics and econometrics, arts and humanities, and history all feature prominently among the fields represented in its pages. This breadth is not incidental. The Lancet has long engaged with the structural, economic, and humanistic dimensions of health, publishing work on health equity, the social determinants of disease, global burden studies, and the political economy of healthcare systems. Authors from sociology, economics, public health, history of medicine, and related disciplines will find a genuine audience here, provided their work speaks to health-relevant questions with appropriate rigor and clarity.
02 Recent Representative Work
The following papers, all published in 2025, illustrate the scope and ambition of work currently appearing in The Lancet. Authors preparing a submission should read these carefully to calibrate the scale, methodology, and framing the journal favors.
The presence of the updated CONSORT 2025 statement among the most-cited recent papers is itself a signal: The Lancet takes reporting standards seriously and actively participates in shaping them.
03 Common Methodology Concerns
Reviewers at journals like The Lancet apply rigorous scrutiny to the methodological foundations of every submission, and the concerns most frequently raised reflect the clinical and epidemiological traditions that dominate its pages. Authors should approach these not as bureaucratic hurdles but as genuine quality markers that strengthen the credibility of their findings.
Adherence to established reporting guidelines (CONSORT for randomised trials, STROBE for observational studies, PRISMA for systematic reviews and meta-analyses) is a baseline expectation, not an optional enhancement. These frameworks exist because incomplete reporting makes it impossible for readers, clinicians, and policymakers to evaluate whether a study's conclusions are trustworthy. If your study design maps onto one of these frameworks, use it explicitly and completely, and state in your methods section which guideline you followed.
Sample size justification and power analysis are equally non-negotiable for quantitative work. A study that cannot demonstrate it was adequately powered to detect a clinically or practically meaningful effect is vulnerable to the criticism that null results are uninformative and positive results may be inflated. Reviewers will look for a clearly stated primary outcome, an a priori effect size estimate grounded in prior literature, and a power calculation that connects these to your final sample. Alongside this, the handling of missing data deserves careful attention. Ad hoc exclusions or undisclosed imputation strategies can introduce bias that undermines otherwise sound designs. Intention-to-treat analysis, where applicable, should be the default, with per-protocol analyses clearly labeled as secondary.
Finally, for experimental and quasi-experimental work, the description of blinding, randomization procedures, and allocation concealment must be precise and complete. Vague language, such as "participants were randomly assigned," is insufficient. Reviewers will want to know the specific randomization method, who generated the sequence, who enrolled participants, and what steps were taken to prevent foreknowledge of assignment.
It is worth acknowledging that not all work submitted to The Lancet is experimental or quantitative. Qualitative and mixed-methods research on health systems, patient experience, and social determinants of health appears in the journal, and rigor in these contexts means something different: transparent coding frameworks, reflexivity statements, clear audit trails, and honest engagement with the limits of transferability. The standards differ, but the underlying demand for transparency and systematic documentation is the same.
04 Statistical Reporting and Replication
The past decade has fundamentally reshaped expectations around statistical reporting across the health and social sciences, and authors submitting to The Lancet should be conversant with these evolving norms. The replication crisis, which demonstrated that a substantial proportion of published findings in psychology, medicine, and related fields could not be reproduced, has raised the bar for methodological transparency, open materials, and honest reporting of null or inconclusive results. This is not merely an academic debate; it has practical consequences for how reviewers read manuscripts and how editors weigh evidence.
Pre-registration of hypotheses and analysis plans, through platforms such as OSF or AsPredicted, has become an increasingly valued practice because it guards against HARKing (Hypothesizing After Results are Known), which inflates false-positive rates and erodes the credibility of the literature. Pre-registration does not constrain exploratory analysis; it simply requires authors to be transparent about which analyses were planned in advance and which emerged from the data. This distinction matters enormously to reviewers who are trying to assess the evidential weight of your findings.
Effect size reporting alongside p-values, or in some contexts instead of them, reflects a broader shift away from null-hypothesis significance testing as the sole arbiter of a finding's importance. A statistically significant result with a negligible effect size may be scientifically unimportant; a non-significant result from an underpowered study tells us very little. Confidence intervals, standardized effect sizes, and measures of practical significance give readers the information they need to make their own judgments.
For qualitative and interpretive work, the replication conversation translates differently. Replication in the strict sense is neither expected nor always meaningful for ethnographic, historical, or discourse-analytic research. What is expected is a different kind of transparency: detailed description of data collection and analysis procedures, reflexivity about the researcher's positionality, and an audit trail sufficient for a reader to evaluate how interpretations were reached. These are not lesser standards. They are the appropriate standards for the epistemological commitments of the work.
05 Pre-submission Checklist
Tick each item as your manuscript clears it. Your progress is saved in this browser.
06 How PeerPanel Reviews Your Manuscript
Before your manuscript reaches The Lancet's editorial team, PeerPanel runs it past five specialist agents, each focused on a distinct dimension of manuscript quality.
Evaluates experimental design, controls, and reproducibility — the methodological backbone reviewers scrutinize first.
Checks statistics across 18 named failure modes: test selection, sample-size adequacy, missing-data handling, and multiple-comparison correction.
Assesses whether citation coverage is current and complete, and whether novelty claims are well-positioned against existing literature.
Reviews abstract completeness, structural clarity, and academic tone — making sure the argument flows and the abstract represents the findings.
Identifies missing comparisons and checks whether conclusions generalize appropriately beyond the scope of your data.
Then they deliberate, cross-examining, rebutting, and retracting unsupported claims.
Adversarial refinement.After each agent reviews independently, PeerPanel runs a deliberation phase where agents challenge each other's findings and retract claims that aren't adequately supported. The result is a more rigorous, internally consistent report than any single-pass review. See a sample review →